February Health Impact Report 2010

Transcription

1 February Health Impact Report 1,391,742 Feb'10 DALYs: 7.5% of strategic target goal is 14% 26% decrease from Feb'09 Feb' 10 DALYs include: :: 1,350,675 product s :: 41,067 BCC DALYs todate in 9 countries: Cambodia, El Salvador, Honduras, India, Kenya, Laos, Nicaragua, Russia, and South Africa (see R&M KIX for specific behaviour change behind the impact) Feb' 10 CYPs: :: 2,036,171 CYPs, 3% decrease from Feb' 09 Starting Feb' 10, two new metrics have been included in the Health Impact report package: :: Price to Consumer :: Trade Margin The reason we have these two new metrics is to regularly monitor the price P and encourage more active price management. The two new metrics are introduced for male condoms only because male condoms are the biggest DALY producers among sold products, and our most common, and thus comparable, product. :: To draw attention to those brands that are sold at significantly under average prices, we flagged brand prices that are 8 (or less) of the PSI regional average consumer price. :: To highlight where we might increase our cost recovery by reducing trade margins, we flagged brands that offer a total trade margin (consumer price less lowest trade price) of 12 of more of the PSI regional average trade margin. :: The February Health Impact Report does not include program targets because they are not complete yet. We will include them in the March Health Impact Report if the coutry programs have finalized them by then. :: Strategic Target, YearEnd Performance and Program Estimate DALYs 24,000,000 20,570,714 20,000,000 18,513,643 16,000,000 12,000,000 8,000,000 10,285,357 10,285,357 12,342,429 9,538,469 14,399,500 13,400,382 16,456,572 15,208,244 9,631,837 (annualized) 4,000,000 Strategic Target YearEnd Performance This report was produced with DALY translation model version 13. February Health Impact Report Executive Summary Page 1

2 :: s Averted by Region & Health Area (% Change from Prior Year ) All regions except Latin America & Caribbean experienced significant drop relative to Feb' 09. :: WCA: decrease in malaria nets distribution in Mali, Nigeria and CongoKinshasa :: EA: decrease in malaria nets distribution in Mozambique and Malwi; KO123 tab (with and without net) in Tanzania :: SA: decrease in Permanets distribution in Zambia; VCT clients in Zimbabwe and condom in South Africa :: Asia & EE: decrease in VSC and TB DOTS in Pakistan; condom, OCs and ORS in India DALYs 900, , ,000 62% Child Survival Malaria Control 600, ,000 46% 15% 4 35% Reproductive Health HIV & TB 400, ,000 29% 16% 15% 25% 200, , West & Central Africa East Africa Southern Africa 5% 1% 81% Latin America and Caribbean 8% 7 16% Asia and Eastern Europe :: s Averted by Health Area & Region (% Change from Prior Year ) Feb'10 DALYs from all health areas except reproductive health dropped relative to Feb'09. :: Feb'10 HIV DALYs dropped relative to Feb'09 due to the decrease in VCT clients in Zimbabwe. :: Malaria Feb'10 DALYs dropped significantly relative to Feb'09 due to the decrease in malaria nets distribution in Mali, Mozambique and Malawi and KO 123 tab in Tanzania. :: Child survival Feb'10 DALYs dropped from Feb'09 because of the decrease in safe water products distribution in Ethiopia, Uganda and Zambia. :: Feb'10 reproductive health DALYs slighly increased from Feb'09 thanks to IUDs program in Nigeria. DALYs 1,000, ,000 96% 800, ,000 Asia and Eastern Europe 600, , , ,000 2% 15% 11% 2% 2 3% 42% 46% Latin America and Caribbean Southern Africa East Africa West and Central Africa 200, ,000 17% 39% 31% HIV & TB Reproductive Health Malaria Control Child Survival February Health Impact Report Executive Summary Page 2

3 :: DALYs by Month by Region West & Central Africa and Southern Africa regions experienced a significant drop in Feb'10 DALYs relative to Jan'10 because of malaria net distribution campaigns in Rwanda (ITN) and Zimbabwe (Olyset) in Jan'10. DALYs 1,500,000 1,200, , , ,000 Asia and Eastern Europe East Africa West and Central Africa Southern Africa Latin America and Caribbean Mar' 09 Apr' 09 May' 09 Jun' 09 Jul' 09 Aug' 09 Sep' 09 Oct' 09 Nov' 09 Dec' 09 Jan' 10 Feb' 10 :: DALYs by Month by Health Area Feb' 10 DALYs for all health areas except malaria control increased from Jan'10. Malaria feb'10 DALYs dropped significantly from Jan'10 due to massive malaria net distribution campaigns in Rwanda in Jan'10. DALYs 2,500,000 2,000,000 1,500,000 1,000, ,000 Child Survival Mar' 09 Apr' 09 May' 09 Jun' 09 Jul' 09 Aug' 09 Sep' 09 Oct' 09 Nov' 09 Dec' 09 Jan' 10 Feb' 10 HIV & TB Reproductive Health Malaria Control February Health Impact Report Executive Summary Page 3

4 :: DALYs from Products Distributed for Free 43% of our DALYs are from free products. Malaria nets account for 6 of free DALYs. DALYs 10,000,000 Free Permanet 8,000,000 Free Olyset Free Condom Free KO123 with net 54% 6,000,000 Free ITN Free KO123 Free Retreatment 47% Free Basic Care Package 4,000,000 Free VCT Single Free IconMaxx Free Safe Water Solution 43% 2,000,000 Free Malaria PPT (ACT) Free IUD Free Implant 5 Free VCT Couple 1 9% Other Free Products 23% 28% Annualized :: Change in product DALYs ( vs. ) Condom DALYs down (Nigeria & South Africa) VCT DALYs down (Zimbabwe, Mozambique & Zambia) 25 HIV & TB 2,738% 1,165% 839% 485% 257% OCs DALYs down (India & Nigeria) Reproductive Health % 39% 27% 14% 4% 27% 36% 41% 58% 59% 66% 4% 6% 8% 2 36% 78% Free Female Condom Basic Care Pakage MC (HIVNegative) MC (HIVUnknown) Condom STI Kit+ Female Condom Free Condom TB DOTS VCT Couple VCT Single + Preliminary figures for STI Kit until external review is done. Implant 5 IUD Injectable 3 Medical Abortion Injectable 1 Injectable 2 Multivit EC Iron Folic Tab Cycle Beads OCs Implant 3 Clean Delivery Kit VSC 20 Permanet DALYs down (Mali, Malawi & Nigeria) Olyset DALYs down (Mozambique) Malaria Control 535% 354% SWS DALYs down (Ethiopia, Uganda & Zambia) ORS DALYs down (India) Child Survival % 53% 6 86% 97% 16% 35% 51% 64% ITN Malaria PPT (ACT) Olyset KO123 with net Malaria RDK LLIN KO123 Diarrhea Treatment Kit PUR ORS Safe Water Solution Water Treatment Tablets Sprinkles Pneumonia PPT Zinc February Health Impact Report Executive Summary Page 4

5 :: CYPs, Cases Averted and Deaths Averted CYPs, Cases and Deaths West and Central Africa East Africa Southern Africa Latin America and the Caribbean Asia and Eastern Europe PSI GLOBAL HIV & TB :: HIV Cases Averted 5,012 6,132 8, ,506 :: STI Deaths Averted :: TB Deaths Averted Reproductive Health :: CYP 631, , ,316 89, ,553 2,036,171 :: Maternal Deaths Averted 1, ,511 :: Unintended Pregnancies Averted 186,796 84,797 81,663 15, , ,960 Malaria Control :: Malaria Cases Averted 634,981 1,121, ,467 39,071 1,899,092 :: Malaria Deaths Averted 5,958 8, ,267 Child Survival :: Diarrhea Cases Averted 57, , ,257 12,769 8, ,260 :: Diarrhea Deaths Averted ,427 :: Nutrition Deaths Averted :: Pneumonia Cases Averted :: Pneumonia Deaths Averted :: CYPs by Method (% Change from Prior Year) The largest increase between Feb' 09 and Feb' 10 was in IUD (Nigeria, Nepal, Pakistan and India). Million CYPs Growth in CYPs by Product: 2000 to Annualized % Change over the prior year 18% 5% 7% 6% 4% 3% 14% 14% 1% VFT Free Female Condom Medical Abortion Implant 3 Injectable 1 Female Condom SDM (Cycle Beads) 8 24% Implant % Emergency Contraception VSC Injectable 2 2 Free Condom Injectable Annualized IUD OCs Condom February Health Impact Report Executive Summary Page 5

6 :: Product DALY HIV & TB Reproductive Health Malaria Control Child Survival Product ' 10 DALYs Absolute Change vs ' 09 % Change vs ' 09 Condom 550,307 (22,600) 4% 1) Condom 550,307 Basic Care Package* 29,897 27,534 1,165% 2) Olyset LLIN* 179,568 VCT Single* 29,731 (57,861) 66% 3) ITN* 139,775 Free Condom 27,668 (19,406) 41% 4) IUD* 71,832 Male Circumcision (HIVNegative)* 8,668 7, % 5) Malaria PPT (ACT) 51,542 Female Condom 4,365 (2,475) 36% 6) Retreatment KO123 net* 48,579 VCT Couple* 4,147 (6,055) 59% 7) Permanet / Netprotect* 44,622 TB DOTS 4,020 (5,574) 58% 8) OCs 39,299 Male Circumcision (HIVUnknown)* 2,021 1, % 9) Injectable 3 31,130 STI Kit + 1,481 (537) 27% 10) Safe Water Solution 30,940 Free Female Condom ,738% 11) Basic Care Package* 29,897 Needle & Syringe NA 12) VCT Single* 29,731 NVP (Mother and Baby) (1,240) 10 13) Free Condom 27,668 NVP (Mother Only) (272) 10 14) Implant 5* 14,852 IUD* 71,832 33,410 87% 15) Retreatment IconMaxx* 10,854 OCs 39,299 (9,877) 2 16) Male Circumcision (HIVNegative)* 8,668 Injectable 3 31,130 8,767 39% 17) ORS 8,236 Implant 5* 14,852 10, % 18) Injectable 2 6,454 Injectable 2 6, ) Female Condom 4,365 Emergency Contraception 2,877 (121) 4% 20) VCT Couple* 4,147 Medical Abortion 1, % 21) TB DOTS 4,020 SDM (Cycle Beads)* 1,578 (140) 8% 22) Diarrhea Treatment Kit 3,652 Misoprostol NA 23) Water Treatment Tablets 2,925 Injectable % 24) Emergency Contraception 2,877 Clean Delivery Kit 485 (1,744) 78% 25) Retreatment KO123* 2,269 Iron Folic Acid Tablet 471 (28) 6% 26) Male Circumcision (HIVUnknown)* 2,021 Multivitamin 300 (1) 27) Medical Abortion 1,763 Implant 3* 167 (93) 36% 28) SDM (Cycle Beads)* 1,578 VSC* 0 (8,499) 10 29) STI Kit + 1,481 Olyset LLIN* 179,568 (90,764) 34% 30) Malaria RDK 1,430 ITN* 139, , % 31) Sprinkles 1,193 Malaria PPT (ACT) 51,542 (21,835) 3 32) Misoprostol 939 Retreatment KO123 net* 48,579 (54,937) 53% 33) Retreatment 720 Permanet / Netprotect* 44,622 (279,780) 86% 34) PUR 593 Retreatment IconMaxx* 10,854 10,854 NA 35) Injectable Retreatment KO123* 2,269 (65,014) 97% 36) Clean Delivery Kit 485 Malaria RDK 1,430 (2,108) 6 37) Iron Folic Acid Tablet 471 Retreatment % 38) Free Female Condom 460 Safe Water Solution 30,940 (16,547) 35% 39) Pneumonia PPT 333 ORS 8,236 (1,570) 16% 40) Multivitamin 300 Diarrhea Treatment Kit 3,652 2, % 41) Implant 3* 167 Water Treatment Tablets 2,925 (3,046) 51% 42) Needle & Syringe 140 Sprinkles 1,193 (2,114) 64% 43) Infant Fortified Food PUR ) NVP (Mother and Baby) Pneumonia PPT 333 (1,371) 8 45) NVP (Mother Only) Zinc 0 (169) 10 46) VSC* Infant Fortified Food 0 0 NA 47) Zinc Deworming Tablets 1 NA NA NA 48) Deworming Tablets 1 N/A * Multiyear protection product + Preliminary figures for STI Kit until external review is done. 1 A DALY for Deworming Tablets will be developed in if Deworming Tablets are still being distributed then. No. s Ranked by Product February Health Impact Report Executive Summary Page 6

7 :: Country DALY Asia and Eastern Europe Latin America and Caribbean Southern Africa East Africa West and Central Africa Country ' 10 DALYs Absolute Change vs % Change vs ' ' No. s Ranked by Country Nigeria 196,208 (80,908) 29% 1) Kenya 273,182 Rwanda 140, , % 2) Nigeria 196,208 CongoKinshasa 27,311 (13,269) 33% 3) Rwanda 140,495 Cameroon 18,559 1,968 12% 4) Zimbabwe 133,250 Mali 14,879 (122,932) 89% 5) Tanzania 77,677 Benin 13,540 11, % 6) Mozambique 59,705 Togo 13,239 2,633 25% 7) Pakistan 55,944 Burkina Faso 10, % 8) South Africa 48,689 Guinea 7,204 1,887 35% 9) Zambia 44,280 Burundi 1, ) Uganda 43,563 Cote d'ivoire 1,140 (910) 44% 11) Malawi 39,008 Haiti 760 (2,054) 73% 12) India 35,278 Liberia NA 13) CongoKinshasa 27,311 C.A.R. 8 (857) 99% 14) Cameroon 18,559 Kenya 273,182 18,146 7% 15) Myanmar 14,955 Tanzania 77,677 (108,055) 58% 16) Mali 14,879 Mozambique 59,705 (95,527) 62% 17) Swaziland 14,519 Uganda 43, % 18) Benin 13,540 Malawi 39,008 (57,748) 6 19) Togo 13,239 Sudan 8,093 3,902 93% 20) Madagascar 12,937 Ethiopia 2,446 (13,895) 85% 21) Cambodia 10,632 Somaliland 60 (1,953) 97% 22) Lesotho 10,406 Angola 0 (16,829) 10 23) Burkina Faso 10,191 Zimbabwe 133,250 (7,902) 6% 24) Sudan 8,093 South Africa 48,689 (38,424) 44% 25) Guinea 7,204 Zambia 44,280 (31,665) 42% 26) Botswana 5,118 Swaziland 14,519 3,489 32% 27) Nepal 4,866 Madagascar 12,937 (8,722) 4 28) Namibia 3,044 Lesotho 10,406 (3,099) 23% 29) Ethiopia 2,446 Botswana 5,118 (4,190) 45% 30) Burundi 1,569 Namibia 3,044 (2,149) 41% 31) Guatemala 1,485 Guatemala 1,485 1, % 32) Dominican Republic 1,183 Dominican Republic 1, ) Cote d'ivoire 1,140 El Salvador % 34) El Salvador 932 Nicaragua % 35) Vietnam 840 Paraguay % 36) Haiti 760 Panama % 37) Nicaragua 665 Honduras % 38) Paraguay 623 Costa Rica % 39) Panama 503 Mexico % 40) Honduras 276 Caribbean 8 8 NA 41) Laos 250 Belize 0 (20) 10 42) Kazakhstan 243 Pakistan 55,944 (11,898) 18% 43) Kyrgyzstan 232 India 35,278 (11,831) 25% 44) Thailand 142 Myanmar 14, % 45) Liberia 111 Cambodia 10,632 (2,859) 21% 46) Romania 109 Nepal 4,866 3, % 47) Tajikistan 97 Vietnam 840 (285) 25% 48) China 85 Laos 250 (80) 24% 49) Costa Rica 83 Kazakhstan % 50) Somaliland 60 Kyrgyzstan % 51) Mexico 31 Thailand % 52) Papua New Guinea 21 Romania 109 (78) 42% 53) Caribbean 8 Tajikistan 97 (42) 3 54) C.A.R. 8 China 85 (173) 67% 55) Belize 0 Papua New Guinea ) Angola 0 Russia 0 0 NA 57) Russia 0 February Health Impact Report Executive Summary Page 7

8 :: PSI Country Programs West and Central Africa Benin Burkina Faso Burundi C.A.R. Cameroon CongoKinshasa Cote d Ivoire Guinea Haiti Liberia Mali Nigeria Rwanda Togo East Africa Angola Ethiopia Kenya Malawi Mozambique Somaliland Sudan Tanzania Uganda Southern Africa Botswana Lesotho Madagascar Namibia South Africa Swaziland Zambia Zimbabwe Latin America and the Caribbean Central America Belize Costa Rica El Salvador Guatemala Honduras Nicaragua Panama Caribbean Antigua Barbados Dominica Grenada Jamaica St. Kitss St. Lucia St. Martin St. Vincent Suriname Trinidad Other LAC countries Dominican Republic Mexico Paraguay Asia and Eastern Europe Asia Cambodia China India Kazakhstan Kyrgyzstan Laos Myanmar Nepal Pakistan Papua New Guinea Thailand Tajikistan Vietnam Eastern Europe Romania Russia February Health Impact Report Executive Summary Page 8

9 :: Products by Health Area HIV & TB Basic Care Package (BCP) Condom (Male Condom) Female Condom Free Condom (Free Male Condom) Free Female Condom Lubricants (A, B, C, D, E) Male Circumcision (HIVNegative)* Male Circumcision (HIVUnknown)* Needle & Syringe NVP (Mother and Baby) NVP (Mother Only) STI Kit + TB DOTS TB Prevention VCT Concordant Couple (HIVNegative)* VCT Concordant Couple (HIVPositive)* VCT Discordant Couple (HIVNegative)* VCT Discordant Couple (HIVPositive)* VCT Individual (HIVNegative)* VCT Individual (HIVPositive)* Reproductive Health Clean Delivery Kit (CDK) Condom (Male Condom) Cycle beads (SDM)* Emergency Contraception Female Condom Free Condom (Free Male Condom) Free Female Condom Intrauterine Device* Iron Folic Acid Hormonal Implant 3year* Hormonal Implant 5year* Injectable 1month Injectable 2month Injectable 3month Medical Abortion Misoprostol Multivitamin Oral Contraceptives Vaginal Foaming Tablets Voluntary Surgical Contraception (VSC)* Malaria Control Insecticide Treated Net (ITN)* Malaria PPT (ACT) Malaria PPT (NonACT) Malaria RDK (Rapid Diagnostic Kit) Netprotect* Olyset LLIN* Permanet LLIN* Retreatment Retreatment IconMaxx* Retreatment KO 123* Retreatment KO 123 Net* Child Survival Deworming Tablet 1 Diarrhea Treatment Kit (DTK) Infant Fortified Food ORS Pneumonia PPT PUR Safe Water Solution Sprinkle Water Treatment Tablets (Chlorine Tabs) Zinc * Product with multiyear protection + Preliminary figures for STI Kit until external review is done. 1 A DALY for Deworming Tablets will be developed in if Deworming Tablets are still being distributed then. Data for male circumcision, TB DOTS and VCT come from Health Service Database February Health Impact Report Executive Summary Page 9

10 :: Table of Contents I. Summary Tables CYPs, Cases, and Deaths Regional Summary 1 DALYs Report by Region 2 DALYs Report by Health Area 3 DALYs Report by Country 4 Distribution Report by Product 10 II. Regional Performance West and Central Africa 19 East Africa 47 Southern Africa 67 Latin America & Caribbean 87 Asia and Eastern Europe 111 III. Price to Consumer 139 IV. Trade Margin 149 February Health Impact Report

11 Summary Tables by Region, Health Area, Country and Product

12 CYPs, Cases, and Deaths by Region 1/ 2/ HIV & TB Reproductive Health Malaria Control Child Survival Cases STI Deaths TB Deaths CYP Maternal Deaths Unintended Pregnancies Malaria Cases Malaria Deaths Diarrhea Cases Diarrhea Deaths Nutrition Deaths Pneumonia Cases Pneumonia Deaths Sum of All Deaths West and Central Africa 5, ,675 1, , ,981 5,958 57, ,275 East Africa 6, , ,797 1,121,573 8, , ,513 Southern Africa 8, , , , , ,820 Americas , ,669 12, Asia and Eastern Europe , ,034 39, , Total 20, ,036,171 2, ,960 1,899,092 15, ,260 1, , /23/ 4:28:28PM Page 1 of 1

13 Monthly DALY Report by Region Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND TOTAL 651,210 1,814,790 1,350,675 (26%) % West and Central Africa 190, , ,214 (15)% 10 HIV & TB 55, ,436 97,259 (14)% 22% Reproductive Health 93, , ,845 7% 35% Malaria Control 36, , ,807 (29)% 42% Child Survival 5,254 5,014 7,303 46% 2% East Africa 279, , ,733 (35)% 10 HIV & TB 90, , ,308 18% 3 Reproductive Health 36,891 68,327 71,020 4% 14% Malaria Control 137, , ,005 (52)% 52% Child Survival 14,779 37,744 22,400 (41)% 4% Southern Africa 113, , ,243 (25)% 10 HIV & TB 84, , ,387 (25)% 64% Reproductive Health 30,630 60,543 67,971 12% 25% Malaria Control (10,782) 52,648 13,668 (74)% 5% Child Survival 9,219 19,291 15,216 (21)% 6% Americas 3,180 3,190 5,789 81% 10 HIV & TB 986 1,461 2,006 37% 35% Reproductive Health 2,179 1,729 3, % 64% Child Survival ,002% 1% Asia and Eastern Europe 64, , ,696 (16)% 10 HIV & TB 11,091 25,882 18,642 (28)% 15% Reproductive Health 49, ,395 96,486 (9)% 78% Malaria Control 2,965 6,678 5,690 (15)% 5% Child Survival 1,243 7,456 2,879 (61)% 2% /23/ 4:33:07PM Page 1 of 1

14 Monthly DALY Report by Health Area Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND TOTAL 651,210 1,814,790 1,350,675 (26%) % HIV & TB 242, , ,604 (11)% 10 West and Central Africa 55, ,436 97,259 (14)% 22 % East Africa 90, , ,308 18% 34 % Southern Africa 84, , ,387 (25)% 4 Americas 986 1,461 2,006 37% Asia and Eastern Europe 11,091 25,882 18,642 (28)% 4 % Reproductive Health 212, , ,033 3% 10 West and Central Africa 93, , ,845 7% 39 % East Africa 36,891 68,327 71,020 4% 18 % Southern Africa 30,630 60,543 67,971 12% 17 % Americas 2,179 1,729 3, % 1 % Asia and Eastern Europe 49, ,395 96,486 (9)% 25 % Malaria Control 165, , ,170 (46)% 10 West and Central Africa 36, , ,807 (29)% 4 East Africa 137, , ,005 (52)% 56 % Southern Africa (10,782) 52,648 13,668 (74)% 3 % Asia and Eastern Europe 2,965 6,678 5,690 (15)% 1 % Child Survival 30,510 69,505 47,869 (31)% 10 West and Central Africa 5,254 5,014 7,303 46% 15 % East Africa 14,779 37,744 22,400 (41)% 47 % Southern Africa 9,219 19,291 15,216 (21)% 32 % Americas ,002% Asia and Eastern Europe 1,243 7,456 2,879 (61)% 6 % /23/ 4:31:07PM Page 1 of 1

15 Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved GRAND TOTAL 651,210 1,814,790 1,350,675 (26%) % West and Central Africa 190, , ,214 (15%) 10 % Benin 9,476 2,450 13, % 3% % HIV & TB 1,290 3,408 2,232 (35)% 1% Reproductive Health 4,123 2,890 6, % 2% Malaria Control (4,815) 1 (100)% Child Survival 4, , % 1% Burkina Faso 5,141 9,637 10,191 6 % 2% % HIV & TB 1,902 3,790 3,852 2% 1% Reproductive Health 3,239 5,847 6,340 8% 1% Burundi 320 1,303 1,569 2 % % HIV & TB (77)% Reproductive Health (80)% Malaria Control ,251 6,602% Child Survival C.A.R (99)% % % HIV & TB (99)% Reproductive Health (99)% Malaria Control Cameroon 12,059 16,591 18, % 4% % HIV & TB 6,148 8,618 8,796 2% 2% Reproductive Health 5,471 7,385 7,911 7% 2% Malaria Control , % Child Survival % CongoKinshasa 16,281 40,580 27,311 (33)% 6% % HIV & TB 6,138 6,614 10,542 59% 2% Reproductive Health 8,761 11,195 14,962 34% 3% Malaria Control 1,341 22,693 1,744 (92)% Child Survival (19)% Cote d'ivoire 96 2,050 1,140 (44)% % % HIV & TB 29 1, (66)% Reproductive Health % Malaria Control % Child Survival (51)% Guinea 4,938 5,317 7, % 2% % HIV & TB (40)% Reproductive Health 4,675 3,574 6,611 85% 1% Malaria Control Child Survival 136 1, (75)% Haiti 760 2, (73)% % % HIV & TB 160 1, (89)% Reproductive Health (52)% Malaria Control 280 (100)% Child Survival Liberia % % % HIV & TB 1 1 Reproductive Health /23/ 4:32:10PM Page 1 of 6 4

16 Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Child Survival Mali 7, ,811 14,879 (89)% 3% % HIV & TB 956 1,300 1,686 3 Reproductive Health 6,368 9,135 13,100 43% 3% Malaria Control , (100)% Child Survival Nigeria 119, , ,208 (29)% 44% % HIV & TB 35,224 78,889 62,709 (21)% 14% Reproductive Health 53,950 94,538 86,242 (9)% 19% Malaria Control 30, ,210 46,059 (55)% 1 Child Survival 475 1,479 1,198 (19)% Rwanda 7,411 18, , % 32% % HIV & TB 1,913 2,405 2,658 11% 1% Reproductive Health 1,625 2,076 2, % Malaria Control 3,800 13, , % 3 Child Survival % Togo 6,558 10,605 13, % 3% % HIV & TB 1,770 4,503 3,883 (14)% 1% Reproductive Health 4,352 4,689 8,803 88% 2% Malaria Control 436 1, (61)% East Africa 279, , ,733 (35%) 10 % Angola 16,829 (100)% % % HIV & TB 1,134 (100)% Reproductive Health 2,827 (100)% Malaria Control 12,376 (100)% Child Survival 492 (100)% Ethiopia 1,477 16,341 2,446 (85)% % % HIV & TB 144 2, (89)% Reproductive Health 328 4, (89)% Malaria Control (100)% Child Survival 1,004 8,507 1,678 (80)% Kenya 151, , ,182 7 % 54% % HIV & TB 31,577 6,454 35, % 7% Reproductive Health 12,472 23,064 26,876 17% 5% Malaria Control 103, , ,502 (7)% 41% Child Survival 4,112 6,347 6,644 5% 1% Malawi 30,576 96,755 39,008 (60)% 8% % HIV & TB 2,951 5,147 4,550 (12)% 1% Reproductive Health 1,168 1,919 1,779 (7)% Malaria Control 21,219 81,230 25,421 (69)% 5% Child Survival 5,238 8,459 7,257 (14)% 1% Mozambique 31, ,233 59,705 (62)% 12% % HIV & TB 21,274 44,220 39,185 (11)% 8% Reproductive Health 5,788 8,978 10,715 19% 2% Malaria Control 3,222 99,005 7,855 (92)% 2% Child Survival 1,248 3,030 1,950 (36)% Somaliland 41 2, (97)% % % /23/ 4:32:30PM Page 2 of 6 5

17 Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Malaria Control 1,940 (100)% Child Survival (18)% Sudan 4,242 4,191 8, % 2% % HIV & TB 227 1, (80)% Reproductive Health 216 1, (81)% Malaria Control 2,480 5,612 1% Child Survival 1, , % Tanzania 39, ,731 77,677 (58)% 15% % HIV & TB 22,051 50,811 40,437 (20)% 8% Reproductive Health 13,468 21,444 22,196 4% 4% Malaria Control 3, ,132 13,186 (88)% 3% Child Survival 1,079 1,345 1,858 38% Uganda 19,862 42,652 43,563 2 % 9% % HIV & TB 12,018 14,763 29,372 99% 6% Reproductive Health 3,451 3,576 8, % Malaria Control 3,655 15,287 4,427 (71)% 1% Child Survival 738 9,025 1,190 (87)% Southern Africa 113, , ,243 (25%) 10 % Botswana 2,328 9,308 5,118 (45)% 2% % HIV & TB 1,763 5,718 3,863 (32)% 1% Reproductive Health 565 1,988 1,256 (37)% Malaria Control Child Survival 1,602 (100)% Lesotho 4,915 13,505 10,406 (23)% 4% % HIV & TB 4,166 12,174 8,827 (27)% 3% Reproductive Health 750 1,331 1,580 19% 1% Madagascar (2,911) 21,659 12,937 (40)% 5% % HIV & TB 377 1,817 1,646 (9)% 1% Reproductive Health 2,979 8,367 13,693 64% 5% Malaria Control (11,325) 5,605 (9,907) (277)% (4)% Child Survival 5,059 5,870 7,506 28% 3% Namibia 1,884 5,192 3,044 (41)% 1% % HIV & TB 1,005 2,399 1,282 (47)% Reproductive Health (47)% Malaria Control 543 1,992 1,334 (33)% South Africa 25,060 87,113 48,689 (44)% 18% % HIV & TB 19,729 68,406 38,130 (44)% 14% Reproductive Health 5,331 18,707 10,558 (44)% 4% Swaziland 7,593 11,031 14, % 5% % HIV & TB 6,501 10,335 12,971 26% 5% Reproductive Health 1, , % 1% Child Survival 6 (100)% Zambia 22,736 75,944 44,280 (42)% 16% % HIV & TB 9,325 24,933 20,391 (18)% 7% Reproductive Health 9,504 9,091 17,402 91% 6% Malaria Control 32,313 (100)% Child Survival 3,907 9,608 6,487 (32)% 2% /23/ 4:32:30PM Page 3 of 6 6

18 Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Zimbabwe 52, , ,250 (6)% 49% % HIV & TB 41, ,639 88,278 (17)% 32% Reproductive Health 10,074 19,569 21, % Malaria Control 12,738 22,241 75% 8% Child Survival 253 2,205 1,223 (45)% Americas 3,180 3,190 5,789 81% 10 % Antigua 2 2 % % % HIV & TB Reproductive Health 1 1 Barbados 2 2 % % % HIV & TB 1 1 Reproductive Health 2 2 Belize 20 (100)% % % HIV & TB 16 (100)% Reproductive Health 4 (100)% Costa Rica % 1% % HIV & TB % Reproductive Health % 1% Dominica % % % HIV & TB Reproductive Health Dominican Republic 592 1,071 1,117 4 % 19% % HIV & TB % 11% Reproductive Health % 8% Child Survival 3 5 Dominican Republic Panam ,655 % 1% % Child Survival ,655% 1% El Salvador % 16% % HIV & TB % 5% Reproductive Health % Grenada % % % HIV & TB Reproductive Health Guatemala 1, , % 26% % HIV & TB % 6% Reproductive Health , % 19% Honduras % 5% % HIV & TB % 2% Reproductive Health % 2% Mexico % 1% % HIV & TB % Reproductive Health % Nicaragua % 11% % HIV & TB (5)% 2% Reproductive Health % 9% /23/ 4:32:30PM Page 4 of 6 7

19 Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Panama % 9% % HIV & TB % 5% Reproductive Health % 3% Paraguay % 11% % HIV & TB (7)% 2% Reproductive Health % 9% St. Kitss % % % HIV & TB Reproductive Health St. Lucia 1 1 % % % HIV & TB Reproductive Health 1 1 St. Martin % % % HIV & TB Reproductive Health St. Vincent % % % HIV & TB Reproductive Health Suriname 1 1 % % % HIV & TB Reproductive Health 1 1 Trinidad 2 2 % % % HIV & TB Reproductive Health 1 1 Asia and Eastern Europe 64, , ,696 (16%) 10 % Cambodia 8,240 13,491 10,632 (21)% 9% % HIV & TB 3,643 4,170 4,187 3% Reproductive Health 2,436 3,308 2,796 (15)% 2% Malaria Control 2,066 6,013 3,554 (41)% 3% Child Survival China (67)% % % HIV & TB (51)% Reproductive Health (51)% Malaria Control (88)% India 22,992 47,109 35,278 (25)% 29% % HIV & TB 3,065 6,620 5,003 (24)% 4% Reproductive Health 19,247 35,724 29,574 (17)% 24% Child Survival 681 4, (85)% 1% Kazakhstan % % % HIV & TB Reproductive Health % Kyrgyzstan % % % HIV & TB 3 (100)% Reproductive Health % Laos (24)% % % HIV & TB (28)% /23/ 4:32:30PM Page 5 of 6 8

20 Monthly DALY Report by Country Year: DALY 2/ Percentage Change Percentage of Category Annual DALY Target Percentage of Target Achieved Reproductive Health % Malaria Control 68 (100)% Myanmar 6,943 14,192 14,955 5 % 12% % HIV & TB 3,536 9,429 7,503 (20)% 6% Reproductive Health 2,059 3,426 4, % Malaria Control , % 2% Child Survival % 1% Nepal 4,853 1,450 4, % 4% % Reproductive Health 4,853 1,386 4, % 4% Malaria Control Child Survival 64 (100)% Pakistan 20,630 67,842 55,944 (18)% 45% % HIV & TB 509 4,928 1,266 (74)% 1% Reproductive Health 20,104 61,184 53,481 (13)% 43% Child Survival 17 1,730 1,196 (31)% 1% Papua New Guinea % % HIV & TB % Reproductive Health % Romania (42)% % % HIV & TB (42)% Reproductive Health (42)% Russia % % % HIV & TB Reproductive Health Tajikistan (30)% % % HIV & TB 7 (100)% Reproductive Health (26)% Thailand % % % HIV & TB % Reproductive Health (50)% Vietnam 377 1, (25)% 1% % HIV & TB (21)% Reproductive Health (23)% Child Survival 46 (100)% /23/ 4:32:30PM Page 6 of 6 9

21 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Basic Care Package 72,433 50,222 73,484 2,160 3,302% 352, ,500 29,897 East Africa 72,433 50,222 73,484 2,160 3,302% 352, ,500 29,897 BCC (Behavior Change) ,237 (100)% 25,951 26,755 Asia and Eastern Europe ,237 (100)% 25,951 26,755 Clean Delivery Kit 1,629 7,989 11,266 53,937 (79)% 176, , West and Central Africa ,989 (95)% 32, , East Africa 1, , % 5, , Asia and Eastern Europe 100 6,943 8,100 44,133 (82)% 138, , Condom 74,019,450 87,396, ,439, ,229,808 (6)% 1,012,452,642 9,400,616, ,307 West and Central Africa 25,597,436 26,751,800 45,374,624 50,935,344 (11)% 328,056,799 2,933,126, ,254 East Africa 12,253,628 11,508,408 24,085,704 24,850,103 (3)% 153,410,168 1,216,720, ,737 Southern Africa 11,617,678 11,006,940 23,033,509 22,898,380 1% 133,173, ,550, ,075 Americas 3,490,217 3,906,007 7,088,055 4,814,956 47% 41,651, ,188,657 4,056 Asia and Eastern Europe 21,060,491 34,223,058 40,857,442 45,731,025 (11)% 356,161,132 4,324,029,796 52,185 Deworming Tablets 8,632 61,399 17,164 5, % 490, ,757 East Africa 8,632 58,562 14,264 % 445, ,725 Southern Africa 2,837 2,900 5,850 (50)% 45, ,032 Diarrhea Treatment Kit 109,247 59, ,949 27, % 775,150 1,257,615 3,652 West and Central Africa 22,050 13,462 34,370 26,544 29% 251, ,334 1,032 East Africa 39,124 8,441 49,024 % 140, ,887 1,472 Southern Africa 5,542 4,233 18, ,384% 27,424 45, Asia and Eastern Europe 42,531 33,121 71, ,705% 355, , Emergency Contraception 171, , , ,852 (12)% 2,587,817 10,507,206 2,877 West and Central Africa 84, , , ,420 21% 1,057,457 5,202,171 1,789 Southern Africa 1,940 8,873 16,887 % 26, , Americas 11,311 15,777 25,007 21,659 15% 131, , Asia and Eastern Europe 73, , , ,773 (40)% 1,372,238 4,612, Female Condom 495, , ,682 1,112,971 (29)% 5,646,218 26,129,666 4, /23/ 4:36:27PM 10 Page 1 of 9

22 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE West and Central Africa 123, , , , % 1,374,466 4,537, East Africa 117,009 24, , ,803 (47)% 941,350 2,738, Southern Africa 223, , , ,100 (48)% 2,852,687 17,494,770 2,531 Americas 3,710 1,853 4,710 3,393 39% 55, ,137 2 Asia and Eastern Europe 27,548 42,439 46,702 80,886 (42)% 422,626 1,198, Free Condom 5,231,404 14,026,773 7,224,823 11,880,325 (39)% 160,612, ,955,360 27,668 West and Central Africa 1,012,112 1,011,674 1,180, , % 9,367,941 37,596,276 3,592 East Africa 3,230,352 2,480,124 4,607,179 6,279,534 (27)% 51,577, ,299,683 17,106 Southern Africa 713,845 10,137,370 1,098,205 4,374,264 (75)% 93,847, ,711,190 6,761 Americas 20,196 52,756 37,332 16, % 298, , Asia and Eastern Europe 254, , , ,142 (69)% 5,521,570 14,701, Free Female Condom 26,852 75,299 85,545 8, % 246, , West and Central Africa % 3,600 3,600 East Africa 23,750 53,197 80,914 % 127, , Southern Africa 2,200 16,411 2,200 1,729 27% 65,291 95, Americas 857 3, ,498% 12,308 18,511 Asia and Eastern Europe 45 2,017 1,552 6,550 (76)% 37,576 47,544 1 Implant , ,058 (80)% 14,522 25, East Africa 192 1, % 3,681 3, Southern Africa % 907 1, Asia and Eastern Europe ,003 (96)% 9,934 19, Implant 5 11,349 10,162 20,047 5, , ,520 14,852 West and Central Africa 6,976 6,165 12,548 1, % 20,043 34,510 9,903 East Africa 410 1, ,000 (81)% 32,244 33, Southern Africa 2,843 2,147 5,042 % 43,763 49,059 3,979 Americas ,86 7,245 8, Asia and Eastern Europe % 6,676 7, Infant Fortified Food % 56,625 91, /23/ 4:36:46PM 11 Page 2 of 9

23 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Asia and Eastern Europe % 56,625 91,859 Injectable 1 36,262 35,880 69,923 77,511 (10)% 381,893 1,726, West and Central Africa 5,900 4,523 9, ,35 10,091 70, Americas 4,010 3,139 6,795 % 28,952 49, Asia and Eastern Europe 26,352 28,217 53,328 77,111 (31)% 342,850 1,606, Injectable 2 81, , , ,342 (1)% 1,286,258 10,825,543 6,454 West and Central Africa 33,000 98, , ,100 4% 815,099 7,059,755 4,138 Asia and Eastern Europe 48,240 47, , ,242 (5)% 471,159 3,765,788 2,316 Injectable 3 323, , , ,804 45% 4,169,178 25,230,936 31,130 West and Central Africa 147, , , ,973 (22)% 2,075,381 12,222,745 11,843 East Africa 30,390 49, ,438 45, % 216,548 1,619,865 7,083 Southern Africa 6,621 96, ,620 42, % 682,445 4,851,249 6,915 Americas ,000 5,370 % 40,000 45, Asia and Eastern Europe 138, , , , % 1,154,804 6,491,707 5,237 Iron Folic Acid Tablet 249, , , ,000 (6)% 2,546,400 39,386, Asia and Eastern Europe 249, , , ,000 (6)% 2,546,400 39,386, ITN 36, , , , % 922,996 17,119, ,775 West and Central Africa 1, , ,569 1,603 36,617% 541,136 1,443, ,118 East Africa 35,568 14,892 53,555 99,593 (46)% 239,127 15,533,263 11,658 Southern Africa 95 % 142, ,733 IUD 80,893 63, ,776 79,397 72% 618,082 3,148,757 71,832 West and Central Africa 24,121 6,209 28,461 9, % 73,576 1,067,844 22,738 East Africa 4,510 6,586 6,039 1, % 44,704 51,567 4,825 Southern Africa 2,028 3,150 4, % 25,515 37,114 3,236 Americas 5,380 1,626 7, ,323% 26,484 33, Asia and Eastern Europe 44,854 45,698 90,956 67,350 35% 447,803 1,958,401 40,101 LLIN 84,546 1,861, ,795 1,035,330 (89)% 11,233,502 34,505,043 37,061 West and Central Africa 24,502 1,175,237 40, ,279 (94)% 5,663,766 18,555,307 13, /23/ 4:36:46PM 12 Page 3 of 9

24 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE East Africa 58, ,698 70, ,364 (75)% 3,636,432 10,366,115 22,656 Southern Africa 1, ,448 4, ,977 (96)% 1,546,970 4,502,580 1,335 Asia and Eastern Europe ,710 (93)% 386,334 1,081, Lubricant A 387, , , ,752 56% 3,717,274 20,993,883 Americas 46,520 15,762 66,196 29, % 150, ,237 Asia and Eastern Europe 340, , , ,493 49% 3,566,365 20,059,646 Lubricant B 4,418 14,897 9,240 9,634 (4)% 102, ,231 Asia and Eastern Europe 4,418 14,897 9,240 9,634 (4)% 102, ,231 Lubricant C 2,253 1,873 5,678 3,992 42% 15,038 49,222 West and Central Africa 2,253 1,869 5,678 3,692 54% 14,724 46,853 Americas (100)% 314 2,369 Lubricant E 3,890 3,301 7,939 28,238 (72)% 123, ,816 West and Central Africa ,289 (100)% 95, ,836 Americas 3,890 2,453 7,939 3, % 28,686 99,980 Malaria PPT (ACT) 491, , ,684 1,100,470 (30)% 9,379,305 14,809,606 51,542 West and Central Africa 412, , , ,438 (32)% 7,324,018 11,290,209 44,187 East Africa 51, ,127 59,010 8, % 1,179,613 1,242,793 4,018 Southern Africa 12,690 27,120 33,520 75,964 (56)% 519, ,779 2,282 Asia and Eastern Europe 15,128 22,433 24,173 63,428 (62)% 356,336 1,434,825 1,055 Malaria RDK 14,480 18,760 32,880 81,341 (60)% 533,320 2,144,657 1,430 Asia and Eastern Europe 14,480 18,760 32,880 81,341 (60)% 533,320 2,144,657 1,430 Male Circumcision (HIVNegative) 1,017 2,272 2, % 14,430 19,328 8,668 Southern Africa 1,017 2,272 2, % 14,430 19,328 8,668 Male Circumcision (HIVUnknown) 92 1, % 5,699 7,102 2,021 Southern Africa 92 1, % 5,699 7,102 2,021 Medical Abortion 10,990 8,893 14,935 10,800 38% 46,908 61,843 1,763 Southern Africa % 10,445 10,445 Asia and Eastern Europe 10,990 8,893 14,935 10,800 38% 36,463 51,398 1, /23/ 4:36:46PM 13 Page 4 of 9

25 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Misoprostol 36,990 41,637 61,600 % 460, , East Africa 21,990 26,837 40,600 % 285, , Southern Africa 15,000 14,800 21,000 % 175, , Multivitamin 377, , , ,100 36% 2,580,320 36,138, West and Central Africa 92,400 35, , ,750 (33)% 566,190 12,973, Americas 284, , , ,350 83% 1,982,130 20,517, Asia and Eastern Europe 2,000 (100)% 32,000 2,647,490 Needle & Syringe 36,101 2,858 41,476 % 34,800 76, Americas 2,900 1,967 5,600 % 16,800 22, Asia and Eastern Europe 33, ,876 % 18,000 53, Netprotect 10,000 52,348 23,502 % 265, ,152 7,561 East Africa 10,000 52,348 23,502 % 265, ,152 7,561 NVP (Mother and Baby) 645 (100)% 645 8,635 East Africa 645 (100)% 645 8,635 NVP (Mother Only) 354 (100)% 354 2,422 East Africa 354 (100)% 354 2,422 OCs 1,754,413 2,488,617 3,261,008 4,292,195 (24)% 30,187, ,201,507 39,299 West and Central Africa 699, ,983 1,259,036 1,502,437 (16)% 8,727,474 43,415,184 17,888 East Africa 223, , , ,559 8% 2,402,606 12,417,301 6,725 Southern Africa 188, , , ,170 9% 4,309,120 25,964,738 8,049 Americas 120,597 29, ,156 65, % 518,649 2,517, Asia and Eastern Europe 522,696 1,170, ,048 1,825,824 (51)% 14,229, ,886,526 6,300 Olyset 289, , , ,287 (34)% 6,835,321 15,097, ,568 West and Central Africa ,676 3,887 % 1,384,180 2,270,191 1,251 East Africa 288, , , ,693 (39)% 3,452,724 10,557, ,076 Southern Africa 506,216 69,134 39,594 75% 1,998,417 2,270,574 22,241 ORS 587, , , ,034 (28)% 4,801,600 89,523,735 8,236 West and Central Africa 337, , , ,652 66% 1,370,742 59,140,071 4, /23/ 4:36:46PM 14 Page 5 of 9

26 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE East Africa 188,352 86, , ,112 % 1,138,068 12,465,071 3,582 Asia and Eastern Europe 61,207 9,997 63, ,270 (87)% 2,292,790 17,918, Pneumonia PPT 14,645 12,788 28,433 64,050 (56)% 136, , East Africa 37,250 (100)% 37,250 77,300 Asia and Eastern Europe 14,645 12,788 28,433 26,800 6% 98, , Pregnancy Test 2,820 3,359 6,585 6,485 2% 34,543 96,663 Asia and Eastern Europe 2,820 3,359 6,585 6,485 2% 34,543 96,663 PUR 2,338,986 3,317,688 4,499,737 1,561, % 30,104,720 83,953, West and Central Africa 164, , , ,919 (56)% 4,947,034 9,881, East Africa 1,785,303 2,298,989 2,630, , % 19,915,992 53,250, Southern Africa 1,440 (100)% 1,133,600 1,272,762 Americas 365, ,160 1,580,640 4,800 32,83 412,560 5,846, Asia and Eastern Europe 23, ,366 34, ,032 (85)% 3,695,534 13,702,338 3 Retreatment 40,546 82,327 98,748 79,774 24% 652,924 16,112, West and Central Africa 3,488 (100)% 22,653 1,009,438 East Africa 5,641 24,180 12,901 3, % 207,000 13,043, Asia and Eastern Europe 34,905 58,147 85,847 72,306 19% 423,271 2,060, Retreatment IconMaxx 115, , ,001 % 2,312,784 2,555,785 10,854 East Africa 4,200 86,333 34,200 % 2,197,980 2,232,180 7,873 Asia and Eastern Europe 111,200 70, ,801 % 114, ,605 2,981 Retreatment KO ,911 9, ,282 (97)% 3,969,863 8,486,037 2,269 West and Central Africa % 2,585 3, East Africa 33,472 9, ,438 (97)% 3,967,278 8,482,608 2,075 Retreatment KO123 net 31,000 67, , ,762 (53)% 1,053,127 9,293,890 48,579 East Africa 31,000 67, , ,762 (53)% 1,053,127 9,293,890 48,579 Safe Water Solution 1,119,532 1,320,208 1,795,989 2,972,540 (40)% 16,585,068 67,497,896 30,940 West and Central Africa 66, , , ,535 % 2,461,931 7,999,171 1,898 East Africa 541, , ,891 1,638,173 (48)% 8,172,291 30,750,420 15, /23/ 4:36:46PM 15 Page 6 of 9

27 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Southern Africa 495, , , ,323 (20)% 4,644,608 25,022,409 13,445 Asia and Eastern Europe 15,964 31,098 27, ,509 (88)% 1,306,238 3,725, SDM (Cycle Beads) 2,380 2,058 3,688 4,015 (8)% 38, ,264 1,578 West and Central Africa 800 1,303 1,166 2,403 (51)% 19,368 81, Southern Africa 1, ,522 1,612 56% 19,027 37,811 1,079 Sprinkles 2,275 79, , ,950 (80)% 1,912,110 5,052,029 1,193 Southern Africa 640,350 (100)% 653,400 1,007,220 Asia and Eastern Europe 2,275 79, , ,600 (30)% 1,258,710 4,044,809 1,193 STI Kit 6,011 33,807 36,666 83,276 (56)% 537,804 3,482,810 1,481 West and Central Africa % 2,055 5,004 East Africa 8,180 (100)% 8,920 30,191 Southern Africa 22,816 21,045 51,460 (59)% 395,336 2,751,740 1,072 Asia and Eastern Europe 6,011 10,992 15,621 23,636 (34)% 131, , TB DOTS 408 1, ,586 (73)% 23, ,033 4,020 Asia and Eastern Europe 408 1, ,586 (73)% 23, ,033 4,020 VCT Concordant Couple (HIVNegative) 7,290 6,136 15,716 % 9,982 25,698 2,157 West and Central Africa ,550 % 142 1, East Africa 1, ,510 % 972 3, Southern Africa 4,828 5,055 11,354 % 8,638 19,992 1,759 Asia and Eastern Europe % VCT Concordant Couple (HIVPositive) 848 1,060 2,452 % 1,576 4,028 1,480 West and Central Africa % East Africa % Southern Africa ,218 % 1,398 3,616 1,403 Asia and Eastern Europe % VCT Couple 3,165 24,801 (100)% 103, ,536 West and Central Africa 295 1,474 (100)% 8,708 29,424 East Africa 311 2,536 (100)% 13,646 50, /23/ 4:36:46PM 16 Page 7 of 9

28 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Southern Africa 2,477 20,533 (100)% 79, ,528 Asia and Eastern Europe (100)% 2,156 6,734 VCT Discordant Couple (HIVNegative) % West and Central Africa % East Africa % Southern Africa % Asia and Eastern Europe % VCT Discordant Couple (HIVPositive) % West and Central Africa % East Africa % Southern Africa % Asia and Eastern Europe % VCT Individual (HIVNegative) 77, , ,690 % 301, ,002 16,698 West and Central Africa 21,168 80,993 43,350 % 220, , East Africa 7,648 3,622 12,939 % 5,575 18,514 1,841 Southern Africa 44,092 36,656 88,064 % 65, ,060 13,954 Americas % 2,013 2,515 2 Asia and Eastern Europe 4,270 3,832 8,835 % 6,930 15, VCT Individual (HIVPositive) 10,134 14,714 22,320 % 31,957 54,277 13,033 West and Central Africa 1,695 6,785 2,752 % 19,298 22, East Africa ,621 % 1,084 2, Southern Africa 7,287 7,095 17,475 % 11,098 28,573 11,861 Americas % Asia and Eastern Europe % VCT Single 30, ,630 (100)% 1,168,927 4,459,590 West and Central Africa 12,961 40,289 (100)% 282, ,846 East Africa 2,221 28,984 (100)% 120, ,945 Southern Africa 13, ,807 (100)% 714,612 2,588, /23/ 4:36:46PM 17 Page 8 of 9

29 Monthly Distribution by Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE Americas (26) % 4,184 5,460 Asia and Eastern Europe 1,467 6,550 (100)% 47, ,625 VSC 6,875 (100)% 22, ,797 Asia and Eastern Europe 6,875 (100)% 22, ,797 Water Treatment Tablets 3,227,601 6,151,549 7,294,001 15,174,043 (52)% 77,229, ,217,243 2,925 West and Central Africa 313, , , ,920 39% 5,915,851 7,417, East Africa 2,225,810 1,356,347 3,682,032 9,612,009 (62)% 33,224, ,431,339 1,433 Southern Africa 582,000 4,405,733 2,810,600 5,076,114 (45)% 38,002,638 61,156,944 1,223 Asia and Eastern Europe 106,450 35, ,850 % 87, ,950 Water Vessel 9,446 5,053 12,104 13,108 (8)% 148,935 1,219,271 East Africa 7,768 5,053 10,426 13,108 (20)% 148, ,735 Southern Africa % 2 803,251 Asia and Eastern Europe 1,678 1,678 % 5,285 Zinc 200,960 (100)% 393, ,675 East Africa 900 (100)% 18,600 74,243 Asia and Eastern Europe 200,060 (100)% 374, , /23/ 4:36:46PM 18 Page 9 of 9

30 West & Central Africa

31 CYPs, Cases, and Deaths by Country 1/ 2/ HIV & TB Reproductive Health Malaria Control Child Survival Cases STI Deaths TB Deaths CYP Maternal Deaths Unintended Pregnancies Malaria Cases Malaria Deaths Diarrhea Cases Diarrhea Deaths Nutrition Deaths Pneumonia Cases Pneumonia Deaths Sum of All Deaths West and Central Africa 5, ,675 1, , ,981 5,958 57, ,275 Benin , , , Burkina Faso , , Burundi , , C.A.R Cameroon , ,549 6, CongoKinshasa , ,033 1, , Cote d'ivoire , Guinea 13 26, ,981 7, Haiti 8 10, ,773 6, Liberia 1 2, Mali 87 53, , , Nigeria 3, , ,105 61,893 1,475 28, ,118 Rwanda 132 9, , ,476 4,312 4, ,333 Togo , ,454 2, /23/ 4:30:13PM Page 1 of 5

32 Monthly Distribution by Region and Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE SALES HIV NonHIV West and Central Africa All 97, , ,214 Clean Delivery Kit ,989 (95)% 32, , Condom 25,597,436 26,751,800 45,374,624 50,935,344 (11)% 328,056,799 2,933,126,852 93,731 82, ,254 Diarrhea Treatment Kit 22,050 13,462 34,370 26,544 29% 251, ,334 1,032 1,032 Emergency Contraception 84, , , ,420 21% 1,057,457 5,202,171 1,789 1,789 Female Condom 123, , , , % 1,374,466 4,537, Free Condom 1,012,112 1,011,674 1,180, , % 9,367,941 37,596,276 1,871 1,720 3,592 Free Female Condom % 3,600 3,600 Implant 5 6,976 6,165 12,548 1, % 20,043 34,510 9,903 9,903 Injectable 1 5,900 4,523 9, ,35 10,091 70, Injectable 2 33,000 98, , ,100 4% 815,099 7,059,755 4,138 4,138 Injectable 3 147, , , ,973 (22)% 2,075,381 12,222,745 11,843 11,843 ITN 1, , ,569 1,603 36,617% 541,136 1,443, , ,118 IUD 24,121 6,209 28,461 9, % 73,576 1,067,844 22,738 22,738 LLIN 24,502 1,175,237 40, ,279 (94)% 5,663,766 18,555,307 13,057 13,057 Lubricant C 2,253 1,869 5,678 3,692 54% 14,724 46,853 Lubricant E ,289 (100)% 95, ,836 Malaria PPT (ACT) 412, , , ,438 (32)% 7,324,018 11,290,209 44,187 44,187 Multivitamin 92,400 35, , ,750 (33)% 566,190 12,973, OCs 699, ,983 1,259,036 1,502,437 (16)% 8,727,474 43,415,184 17,888 17,888 Olyset ,676 3,887 % 1,384,180 2,270,191 1,251 1,251 ORS 337, , , ,652 66% 1,370,742 59,140,071 4,060 4,060 PUR 164, , , ,919 (56)% 4,947,034 9,881, /23/ 4:35:09PM Page 1 of 13

33 Monthly Distribution by Region and Product Year: 2/ MONTHLY AVG PREV 3 MONTHS TARGET % CHANGE TOTAL CUMULATIVE SALES HIV NonHIV Retreatment 3,488 (100)% 22,653 1,009,438 Retreatment KO % 2,585 3, Safe Water Solution 66, , , ,535 % 2,461,931 7,999,171 1,898 1,898 SDM (Cycle Beads) 800 1,303 1,166 2,403 (51)% 19,368 81, STI Kit % 2,055 5,004 VCT Concordant Couple (HIV ,550 % 142 1, VCT Concordant Couple (HIV % VCT Couple 295 1,474 (100)% 8,708 29,424 VCT Discordant Couple (HIVN % VCT Discordant Couple (HIVP % VCT Individual (HIVNegative) 21,168 80,993 43,350 % 220, , VCT Individual (HIVPositive) 1,695 6,785 2,752 % 19,298 22, VCT Single 12,961 40,289 (100)% 282, ,846 Water Treatment Tablets 313, , , ,920 39% 5,915,851 7,417, /23/ 4:35:29PM Page 2 of 13